{"output": [["Celgene Corp", "COMP", "Announce", "Preliminary Q4 Revlimid Sales", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Announce", "Preliminary 2017 Unaudited Results and 2018 Financial Guidance", "CONCEPT"], ["Celgene Corp", "COMP", "Sees", "Q4 2017 Adjusted Earnings Per Share", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "FY 2017 Gaap Earnings Per Share", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "Q4 2017 Gaap Loss Per Share", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "FY 2018 Revenue", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "FY 2018 Adjusted Earnings Per Share", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "FY 2020 Revenue", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "FY 2017 Adjusted Earnings Per Share", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "Q4 Revenue", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Sees", "Preliminary Q4 Otezla Sales", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Reaffirming", "2020 Total Revenue and Adjusted Diluted Eps Financial Targets", "CONCEPT"], ["Celgene Corp", "COMP", "Expect", "Full Year 2017 Gaap Operating Margin", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Estimated", "Impact of About $800 Million-About $1,300 Million", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Expect", "EPS for Quarter & Year Ended Dec 31, 2017", "ECON_INDICATOR"], ["Celgene Corp", "COMP", "Expect", "EPS for Full-Year 2018", "ECON_INDICATOR"]], "published": "2018-01-08T17:55:00.000+02:00"}